Ubiquitin‐specific peptidases: Players in bone metabolism

Jianlin Shen,Xiaoning Lin,Feifei Dai,Guoli Chen,Haibin Lin,Bangjiang Fang,Huan Liu

DOI: https://doi.org/10.1111/cpr.13444

IF: 8.755

2023-03-10

Cell Proliferation

Abstract:Mechanical loading up‐regulates the expression of PGE2, which binds to EP2 to inhibit TGFβ signalling through a CYLD‐dependent proteasome mechanism, thereby inhibiting the transactivation of pSmad2/3 and subsequently inhibiting the expression of Sost. The phosphorylation of USP4 by Ck2 can also inhibit the transcription of Sost by inhibiting ubiquitination degradation of SIRT1. Sost then acts as an antagonist of WNT/β‐catenin signalling and a promoter of RANK/RANKL signalling to modulate bone remodelling. In addition, USP53 is involved in the regulation of osteoblast–osteoclast coupling. Mechanistically, USP53 inhibits the interaction between Smad3 and VDR in osteoblasts, resulting in reduced binding of VDR to its cognate elements, thereby inhibiting the activation of RANKL. Osteoporosis is an ageing‐related disease, that has become a major public health problem and its pathogenesis has not yet been fully elucidated. Substantial evidence suggests a strong link between overall age‐related disease progression and epigenetic modifications throughout the life cycle. As an important epigenetic modification, ubiquitination is extensively involved in various physiological processes, and its role in bone metabolism has attracted increasing attention. Ubiquitination can be reversed by deubiquitinases, which counteract protein ubiquitination degradation. As the largest and most structurally diverse cysteinase family of deubiquitinating enzymes, ubiquitin‐specific proteases (USPs), comprising the largest and most structurally diverse cysteine kinase family of deubiquitinating enzymes, have been found to be important players in maintaining the balance between bone formation and resorption. The aim of this review is to explore recent findings highlighting the regulatory functions of USPs in bone metabolism and provide insight into the molecular mechanisms governing their actions during bone loss. An in‐deep understanding of USPs‐mediated regulation of bone formation and bone resorption will provide a scientific rationale for the discovery and development of novel USP‐targeted therapeutic strategies for osteoporosis.

cell biology